
US-based BioLife Solutions, Inc. manufactures and supplies healthcare products globally for biotech and medical sectors.
Founded in Bothell, United States, BioLife Solutions, Inc. is dedicated to manufacturing and supplying advanced healthcare products. The company's core mission is to enhance the quality and efficacy of cell and gene therapies. Their product line includes CryoStor, HypoThermosol, and BloodStor, which are designed to improve the preservation and storage of biological materials. BioLife Solutions primarily serves the biotechnology and medical sectors worldwide, focusing on providing innovative solutions that support the development and delivery of life-saving therapies.
Notable affiliated individuals include key industry experts and leaders in biotechnology. BioLife Solutions has attracted significant investment from various stakeholders committed to advancing healthcare technology. The company has achieved recognition for its high-quality biopreservation media, contributing to the success of numerous clinical trials and commercial therapies. Overall, BioLife Solutions has made a substantial impact on the biotech and medical industries by improving the preservation and transport of critical biological materials, thereby enhancing patient outcomes globally.
Companies similar to BioLife Solutions include Bridge to Life, Lifecore Biomedical, Cryoport and Vivebio.
BioLife Solutions was founded in 1987.
BioLife Solutions' headquarters is located in Bothell, WA, US.
BioLife Solutions' most recent funding round was for $10.4M (USD) in October 2023.
As of Oct 27, 2023, BioLife Solutions has disclosed funding of $99M (USD). Undisclosed round amounts are excluded.
BioLife Solutions has 466 employees as of Feb 6, 2024.
Vivebio